unknown
Stage
1
Investors
About
Delineate builds AI agents to accelerate and improve the design of clinical trials by optimizing trial plans, targeting a $10B market where time savings translate to significant revenue gains.
Explore Delineate's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.